(Q34684090)

3 August 2017

1 reference

title

Direct thrombin inhibitors for percutaneous coronary intervention in the current era of platelet glycoprotein IIb/IIIa inhibition (English)

1 reference

3 August 2017

Joel P Reginelli

1

1 reference

3 August 2017

Derek Chew

series ordinal

2

1 reference

3 August 2017

publication date

1 April 2002

1 reference

Journal of Interventional Cardiology

3 August 2017

published in

1 reference

3 August 2017

volume

15

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

141-146

1 reference

The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01046.X

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01046.X

Direct thrombin inhibitors in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01046.X

Recombinant hirudin in clinical practice: focus on lepirudin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01046.X

The structure of a complex of recombinant hirudin and human alpha-thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01046.X

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01046.X

Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01046.X

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01046.X

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01046.X

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01046.X

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01046.X

Heparin-Induced Thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8183.2002.TB01046.X

10.1111/J.1540-8183.2002.TB01046.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference